About Proleukin
Proleukin was founded in 1998 and is based in Yardley, United States. Operations focus on the healthcare sector, specifically oncology, where a website is maintained to deliver detailed information about cancer treatments and related drugs. Services include educational resources for patients and professionals, with content centered on drug profiles, usage guidelines, and clinical data. The platform serves users across the United States and internationally through its domain.
- Headquarter Yardley, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Iovance Biotherapeutics, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Iovance
(Jan 30, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Proleukin
Detailed funding history for Proleukin
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Proleukin
Proleukin has secured backing from 1 investor. Prominent investors backing the company include Iovance Biotherapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
T-cell therapies for cancer treatment are developed.
|
Locked | Locked | Locked |
Investor details for Proleukin
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Proleukin
Investment portfolio details for Proleukin
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Proleukin
Detailed financials for Proleukin
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Proleukin Comparisons
Peer comparison for Proleukin
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Proleukin
Detailed competitors of Proleukin
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Proleukin
Complete news archive for Proleukin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proleukin
Proleukin was founded in 1998.
Proleukin is headquartered in Yardley, United States. It is registered at Yardley, Pennsylvania, United States.
Shaun Chilton is the current CEO of Proleukin.
Proleukin was founded in 1998 and is based in Yardley, United States. Operations focus on the healthcare sector, specifically oncology, where a website is maintained to deliver detailed information about cancer treatments and related drugs. Services include educational resources for patients and professionals, with content centered on drug profiles, usage guidelines, and clinical data. The platform serves users across the United States and internationally through its domain.
Proleukin has 1 investor. Key investors include Iovance Biotherapeutics.